S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NASDAQ:OMIC

Singular Genomics Systems (OMIC) Stock Price, News & Analysis

$0.52
+0.01 (+1.97%)
(As of 03/27/2024 ET)
Today's Range
$0.48
$0.52
50-Day Range
$0.41
$0.61
52-Week Range
$0.31
$1.32
Volume
110,026 shs
Average Volume
96,086 shs
Market Capitalization
$38.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.68

Singular Genomics Systems MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
30.6% Upside
$0.68 Price Target
Short Interest
Bearish
1.93% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.62mentions of Singular Genomics Systems in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.89 out of 5 stars

Medical Sector

655th out of 939 stocks

Analytical Instruments Industry

17th out of 28 stocks

OMIC stock logo

About Singular Genomics Systems Stock (NASDAQ:OMIC)

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.

OMIC Stock Price History

OMIC Stock News Headlines

Singular Genomics Systems (NASDAQ:OMIC) PT Raised to $0.50
The Small Biotech with a BIG Cancer Solution
There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.
Singular Genomics Sys: Q4 Earnings Insights
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Singular Genomics Systems earnings: here's what to expect
Preview: Singular Genomics Sys's Earnings
Singular Genomics Systems Inc.
Singular Genomics Systems Founder Acquires 4.6% More Stock
Recap: Singular Genomics Sys Q3 Earnings
OMIC Singular Genomics Systems, Inc.
Singular Genomics Systems Inc OMIC
See More Headlines
Receive OMIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/18/2024
Today
3/27/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:OMIC
Fax
N/A
Employees
284
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$0.68
High Stock Price Target
$0.85
Low Stock Price Target
$0.50
Potential Upside/Downside
+30.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-94,820,000.00
Net Margins
-3,257.30%
Pretax Margin
-3,257.30%

Debt

Sales & Book Value

Annual Sales
$2.91 million
Book Value
$2.44 per share

Miscellaneous

Free Float
57,221,000
Market Cap
$38.21 million
Optionable
Optionable
Beta
1.40
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Andrew Spaventa (Age 39)
    Founder, CEO, President & Chairperson of the Board
    Comp: $685.93k
  • Dr. David L. Barker Ph.D. (Age 82)
    Founder, Member of Scientific Advisory Board & Independent Director
    Comp: $63.75k
  • Dr. Eli N. Glezer Ph.D. (Age 55)
    Founder, Chief Scientific Officer & Chair of Scientific Advisory Board
    Comp: $496.5k
  • Mr. Dalen Meeter (Age 46)
    Chief Financial Officer
    Comp: $434.39k
  • Jyotsna Ghai
    Chief Operating Officer
  • Mr. Jorge Velarde Jr. (Age 57)
    MBA, Senior Vice President of Corporate Development & Strategy
  • Mr. Jeff Bullard
    Head of Sales
  • Mr. Vincent Brancaccio (Age 41)
    Head of Human Resources
  • Mr. Samuel Ropp Ph.D. (Age 50)
    Chief Commercial Officer

OMIC Stock Analysis - Frequently Asked Questions

Should I buy or sell Singular Genomics Systems stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares.
View OMIC analyst ratings
or view top-rated stocks.

What is Singular Genomics Systems' stock price target for 2024?

2 brokers have issued twelve-month target prices for Singular Genomics Systems' stock. Their OMIC share price targets range from $0.50 to $0.85. On average, they anticipate the company's stock price to reach $0.68 in the next year. This suggests a possible upside of 30.6% from the stock's current price.
View analysts price targets for OMIC
or view top-rated stocks among Wall Street analysts.

How have OMIC shares performed in 2024?

Singular Genomics Systems' stock was trading at $0.4601 on January 1st, 2024. Since then, OMIC stock has increased by 12.3% and is now trading at $0.5168.
View the best growth stocks for 2024 here
.

When is Singular Genomics Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our OMIC earnings forecast
.

How were Singular Genomics Systems' earnings last quarter?

Singular Genomics Systems, Inc. (NASDAQ:OMIC) released its quarterly earnings results on Monday, March, 18th. The company reported ($0.34) EPS for the quarter. The business had revenue of $1.08 million for the quarter. Singular Genomics Systems had a negative net margin of 3,257.30% and a negative trailing twelve-month return on equity of 45.33%.

What guidance has Singular Genomics Systems issued on next quarter's earnings?

Singular Genomics Systems updated its fourth quarter 2023 earnings guidance on Monday, January, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.0 million-$1.0 million, compared to the consensus revenue estimate of 590000.000.

When did Singular Genomics Systems IPO?

Singular Genomics Systems (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. The company issued 8,500,000 shares at a price of $20.00-$22.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO.

Who are Singular Genomics Systems' major shareholders?

Singular Genomics Systems' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Perceptive Advisors LLC (2.90%), Vanguard Group Inc. (2.55%), Vanguard Group Inc. (2.55%), Weil Company Inc. (0.19%), Bridgeway Capital Management LLC (0.17%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Andrew Spaventa, Eli N Glezer, James E Flynn, Kim P Kamdar, Michael J Pellini and Sheryl L Conley.
View institutional ownership trends
.

How do I buy shares of Singular Genomics Systems?

Shares of OMIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OMIC) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners